Order Article Reprints

Chavez Alvarez AC, Bouzriba C, Ouellette V, Gagné-Boulet M, Patenaude A, Pilote S, C.-Gaudreault R, Simard C, Fortin S. Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models. Pharmaceutics. 2025; 17(2):233. https://doi.org/10.3390/pharmaceutics17020233

Chavez Alvarez, Atziri Corin, Chahrazed Bouzriba, Vincent Ouellette, Mathieu Gagné-Boulet, Alexandre Patenaude, Sylvie Pilote, René C.-Gaudreault, Chantale Simard, and Sébastien Fortin. 2025. "Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models" Pharmaceutics 17, no. 2: 233. https://doi.org/10.3390/pharmaceutics17020233

Chavez Alvarez, A. C., Bouzriba, C., Ouellette, V., Gagné-Boulet, M., Patenaude, A., Pilote, S., C.-Gaudreault, R., Simard, C., & Fortin, S. (2025). Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models. Pharmaceutics, 17(2), 233. https://doi.org/10.3390/pharmaceutics17020233